HALO logo
halo search icon
Emergent BioSolutions Inc.

US$8.15

Price Change Indicator
0.09 (1.12%)
Emergent BioSolutions Inc.
EBS · NYS

Emergent BioSolutions Inc.

Start Trading EBS for Free

US$8.15

Price Arrow0.09 (1.12%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Emergent BioSolutions Inc. Overview

EBS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Weak

About EBS

icon
icon

Telephone

1.240.631.3200

icon

Address

Suite 400, 300 Professional Drive, Gaithersburg, MD 20879

Description

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

EBS Price Chart

Key Stats

Market Cap

US$415.87M

PE

13.30

EV/EBITDA

5.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.61 - 14.06

Trade Value (12mth)

US$2,322,947.00

1 week

1.51%

1 month

0.75%

YTD

-35.57%

1 year

25.35%

All time high

137.61

Key Fundamentals

EPS 3 yr Growth

-123.30%

EBITDA Margin

28.10%

Operating Cashflow

$171m

Free Cash Flow Return

15.10%

ROIC

4.70%

Interest Coverage

3.50

Quick Ratio

2.40

Other Data

Shares Outstanding (Fully Diluted)

56m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EBS Announcements

Latest Announcements

DateAnnouncements
01 May 26
01 May 26
01 May 26
01 May 26
30 April 26

EBS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-14.85-3.60.98locklocklock
EPS (Fully Diluted)
 $locklocklocklock-14.85-3.60.93locklocklock
Growth
 %locklocklocklock-251.775.8127.3locklocklock
PE
 XlocklocklocklockN/AN/A13.3locklocklock
EV/EBITDA
 XlocklocklocklockN/A19.95.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
The current share price of Emergent BioSolutions Inc. (EBS:NYS) is USD$8.15.
What is the 52-week high share price for Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
The 52-week high share price for Emergent BioSolutions Inc. (EBS:NYS) is USD$14.06.
What is the 52-week low share price for Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
The 52-week low share price for Emergent BioSolutions Inc. (EBS:NYS) is USD$5.61.
What is the dividend yield for Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
Emergent BioSolutions Inc. (EBS:NYS) does not pay a dividend.
What was Emergent BioSolutions Inc. (EBS:NYS) last dividend payment?
Halo FAQ
Emergent BioSolutions Inc. (EBS:NYS) does not pay a dividend.
What is the franking level for Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
Emergent BioSolutions Inc. (EBS:NYS) has a franking level of 0.00%.
In which sector is Emergent BioSolutions Inc. (EBS:NYS) classified?
Halo FAQ
Emergent BioSolutions Inc. (EBS:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Emergent BioSolutions Inc. (EBS:NYS)?
Halo FAQ
The current P/E ratio for Emergent BioSolutions Inc. (EBS:NYS) is 13.30.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial